- Home
- KURA vs ETON Comparison
KURA vs ETON Comparison
Compare KURA & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- ETON
- Stock Information
- Founded
- KURA 2014
- ETON 2017
- Country
- KURA United States
- ETON United States
- Employees
- KURA N/A
- ETON N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- KURA Health Care
- ETON Health Care
- Exchange
- KURA Nasdaq
- ETON Nasdaq
- Market Cap
- KURA 492.9M
- ETON 428.5M
- IPO Year
- KURA N/A
- ETON 2018
- Fundamental
- Price
- KURA $5.64
- ETON $19.81
- Analyst Decision
- KURA Strong Buy
- ETON Strong Buy
- Analyst Count
- KURA 12
- ETON 3
- Target Price
- KURA $24.50
- ETON $29.00
- AVG Volume (30 Days)
- KURA 1.2M
- ETON 307.6K
- Earning Date
- KURA 05-01-2025
- ETON 05-13-2025
- Dividend Yield
- KURA N/A
- ETON N/A
- EPS Growth
- KURA N/A
- ETON N/A
- EPS
- KURA N/A
- ETON N/A
- Revenue
- KURA $67,991,000.00
- ETON $48,327,000.00
- Revenue This Year
- KURA $171.90
- ETON $98.26
- Revenue Next Year
- KURA $60.51
- ETON $51.64
- P/E Ratio
- KURA N/A
- ETON N/A
- Revenue Growth
- KURA N/A
- ETON 40.88
- 52 Week Low
- KURA $5.41
- ETON $3.18
- 52 Week High
- KURA $23.48
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- KURA 40.55
- ETON 68.53
- Support Level
- KURA $5.56
- ETON $18.27
- Resistance Level
- KURA $6.51
- ETON $20.70
- Average True Range (ATR)
- KURA 0.42
- ETON 1.40
- MACD
- KURA 0.02
- ETON 0.18
- Stochastic Oscillator
- KURA 13.22
- ETON 66.93
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.